Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 01, 2023 Filed Aug 14, 2023 20:52 UTC |
Lemerond NicoleDirector
|
GrantStock Option · Derivative | 50,000 | $0.00 Strike: $0.76 | $0.00 |
DisclosureSEC source: 0001437749-23-023741 · rdgdoc.xml · derivative · entry 1 Lemerond Nicole · CIK 0001941712 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2033-12-07 F1 · date: This stock option was granted on December 7, 2022, with the exercise price set based on the closing price of the underlying common stock as of that date. The stock option was granted contingent upon stockholder approval of an increase in common shares reserved for the company's stock incentive plan. Such approval occurred on August 1, 2023, so that is the date upon which the stock option is deemed granted pursuant to SEC reporting guidance. Read SEC document |
| August 01, 2023 Filed Aug 14, 2023 20:51 UTC |
Kollintzas Dean GDirector
|
GrantStock Option · Derivative | 50,000 | $0.00 Strike: $0.76 | $0.00 |
DisclosureSEC source: 0001437749-23-023739 · rdgdoc.xml · derivative · entry 1 Kollintzas Dean G · CIK 0001378351 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2033-12-07 F1 · date: This stock option was granted on December 7, 2022, with the exercise price set based on the closing price of the underlying common stock as of that date. The stock option was granted contingent upon stockholder approval of an increase in common shares reserved for the company's stock incentive plan. Such approval occurred on August 1, 2023, so that is the date upon which the stock option is deemed granted pursuant to SEC reporting guidance. Read SEC document |
| August 01, 2023 Filed Aug 14, 2023 20:50 UTC |
CHASE RANDAL DDirector
|
GrantStock Option · Derivative | 50,000 | $0.00 Strike: $0.76 | $0.00 |
DisclosureSEC source: 0001437749-23-023738 · rdgdoc.xml · derivative · entry 1 CHASE RANDAL D · CIK 0001078784 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2033-12-07 F1 · date: This stock option was granted on December 7, 2022, with the exercise price set based on the closing price of the underlying common stock as of that date. The stock option was granted contingent upon stockholder approval of an increase in common shares reserved for the company's stock incentive plan. Such approval occurred on August 1, 2023, so that is the date upon which the stock option is deemed granted pursuant to SEC reporting guidance. Read SEC document |
| August 01, 2023 Filed Aug 14, 2023 20:50 UTC |
McKee Kelly T. Jr.Chief Medical Officer
|
GrantStock Option · Derivative | 15,000 | $0.00 Strike: $0.76 | $0.00 |
DisclosureSEC source: 0001437749-23-023737 · rdgdoc.xml · derivative · entry 1 McKee Kelly T. Jr. · CIK 0001903889 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2033-12-07 F1 · date: This stock option was granted on December 7, 2022, with the exercise price set based on the closing price of the underlying common stock as of that date. The stock option was granted contingent upon stockholder approval of an increase in common shares reserved for the company's stock incentive plan. Such approval occurred on August 1, 2023, so that is the date upon which the stock option is deemed granted pursuant to SEC reporting guidance. F2 · derivative.exercise_date: Stock option becomes exercisable in three equal annual installments on the first three anniversary dates of the grant. Read SEC document |
| August 01, 2023 Filed Aug 14, 2023 20:49 UTC |
Sharkey John W.VP, Business Development
|
GrantStock Option · Derivative | 100,000 | $0.00 Strike: $0.76 | $0.00 |
DisclosureSEC source: 0001437749-23-023736 · rdgdoc.xml · derivative · entry 1 Sharkey John W. · CIK 0001515991 · VP, Business Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2033-12-07 F1 · date: This stock option was granted on December 7, 2022, with the exercise price set based on the closing price of the underlying common stock as of that date. The stock option was granted contingent upon stockholder approval of an increase in common shares reserved for the company's stock incentive plan. Such approval occurred on August 1, 2023, so that is the date upon which the stock option is deemed granted pursuant to SEC reporting guidance. F2 · derivative.exercise_date: Stock option becomes exercisable in three equal annual installments on the first three anniversary dates of the grant. Read SEC document |
| August 01, 2023 Filed Aug 14, 2023 20:48 UTC |
NEWMAN MARK JChief Scientific Officer
|
GrantStock Option · Derivative | 100,000 | $0.00 Strike: $0.76 | $0.00 |
DisclosureSEC source: 0001437749-23-023733 · rdgdoc.xml · derivative · entry 1 NEWMAN MARK J · CIK 0001242123 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2033-12-07 F1 · date: This stock option was granted on December 7, 2022, with the exercise price set based on the closing price of the underlying common stock as of that date. The stock option was granted contingent upon stockholder approval of an increase in common shares reserved for the company's stock incentive plan. Such approval occurred on August 1, 2023, so that is the date upon which the stock option is deemed granted pursuant to SEC reporting guidance. F2 · derivative.exercise_date: Stock option becomes exercisable in three equal annual installments on the first three anniversary dates of the grant. Read SEC document |
| August 01, 2023 Filed Aug 14, 2023 20:46 UTC | GrantStock Option · Derivative | 100,000 | $0.00 Strike: $0.76 | $0.00 |
DisclosureSEC source: 0001437749-23-023727 · rdgdoc.xml · derivative · entry 1 Reynolds Mark · CIK 0001298237 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2033-12-07 F1 · date: This stock option was granted on December 7, 2022, with the exercise price set based on the closing price of the underlying common stock as of that date. The stock option was granted contingent upon stockholder approval of an increase in common shares reserved for the company's stock incentive plan. Such approval occurred on August 1, 2023, so that is the date upon which the stock option is deemed granted pursuant to SEC reporting guidance. F2 · derivative.exercise_date: Stock option becomes exercisable in three equal annual installments on the first three anniversary dates of the grant. Read SEC document |
|
| August 01, 2023 Filed Aug 14, 2023 20:47 UTC |
DODD DAVID ADirector · President, CEO
|
GrantStock Option · Derivative | 250,000 | $0.00 Strike: $0.76 | $0.00 |
DisclosureSEC source: 0001437749-23-023731 · rdgdoc.xml · derivative · entry 1 DODD DAVID A · CIK 0001193607 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2033-12-07 F1 · date: This stock option was granted on December 7, 2022, with the exercise price set based on the closing price of the underlying common stock as of that date. The stock option was granted contingent upon stockholder approval of an increase in common shares reserved for the company's stock incentive plan. Such approval occurred on August 1, 2023, so that is the date upon which the stock option is deemed granted pursuant to SEC reporting guidance. F2 · derivative.exercise_date: Stock option becomes exercisable in three equal annual installments on the first three anniversary dates of the grant. Read SEC document |
| April 24, 2023 Filed Apr 25, 2023 19:13 UTC |
DODD DAVID ADirector · President, CEO
|
PurchaseCommon Stock | 32,000 | $0.64 | $20,444.80 |
DisclosureSEC source: 0001437749-23-011000 · rdgdoc.xml · nonDerivative · entry 1 DODD DAVID A · CIK 0001193607 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 113,870 Read SEC document |
| April 20, 2023 Filed Apr 21, 2023 12:38 UTC | PurchaseCommon Stock | 8,000 | $0.63 | $5,040.00 |
DisclosureSEC source: 0001437749-23-010776 · rdgdoc.xml · nonDerivative · entry 1 Reynolds Mark · CIK 0001298237 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,184 Read SEC document |
|
| September 21, 2022 Filed Sep 23, 2022 15:24 UTC |
CHASE RANDAL DDirector
|
PurchaseCommon Stock | 10,000 | $1.10 | $11,000.00 |
DisclosureSEC source: 0001437749-22-022942 · rdgdoc.xml · nonDerivative · entry 1 CHASE RANDAL D · CIK 0001078784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,613 Read SEC document |
| July 01, 2022 Filed Jul 5, 2022 19:10 UTC |
Sharkey John W.VP, Business Development
|
PurchaseCommon Stock | 1,000 | $0.82 | $820.00 |
DisclosureSEC source: 0001437749-22-016567 · rdgdoc.xml · nonDerivative · entry 1 Sharkey John W. · CIK 0001515991 · VP, Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,860 Read SEC document |
| June 27, 2022 Filed Jun 28, 2022 18:59 UTC |
McKee Kelly T. Jr.Chief Medical Officer
|
PurchaseCommon Stock | 4,464 | $1.12 | $4,999.68 |
DisclosureSEC source: 0001437749-22-016072 · rdgdoc.xml · nonDerivative · entry 1 McKee Kelly T. Jr. · CIK 0001903889 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,185 Read SEC document |
| June 21, 2022 Filed Jun 22, 2022 12:53 UTC |
CHASE RANDAL DDirector
|
PurchaseCommon Stock | 10,000 | $1.21 | $12,100.00 |
DisclosureSEC source: 0001437749-22-015552 · rdgdoc.xml · nonDerivative · entry 1 CHASE RANDAL D · CIK 0001078784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,613 Read SEC document |
| May 05, 2022 Filed May 6, 2022 15:13 UTC |
McKee Kelly T. Jr.Chief Medical Officer
|
PurchaseCommon Stock | 9,722 | $0.72 | $6,999.84 |
DisclosureSEC source: 0001437749-22-011257 · rdgdoc.xml · nonDerivative · entry 1 McKee Kelly T. Jr. · CIK 0001903889 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,721 Read SEC document |
| May 04, 2022 Filed May 5, 2022 20:23 UTC |
McKee Kelly T. Jr.Chief Medical Officer
|
PurchaseCommon Stock | 4,999 | $0.71 | $3,549.29 |
DisclosureSEC source: 0001437749-22-011137 · rdgdoc.xml · nonDerivative · entry 1 McKee Kelly T. Jr. · CIK 0001903889 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,999 Read SEC document |
| December 07, 2021 Filed Dec 8, 2021 22:24 UTC |
SPENCER JOHN N JRDirector
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $3.82 | $0.00 |
DisclosureSEC source: 0001437749-21-028134 · rdgdoc.xml · derivative · entry 1 SPENCER JOHN N JR · CIK 0001270555 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2031-12-07 Read SEC document |
| December 07, 2021 Filed Dec 8, 2021 22:23 UTC |
MCNALLY ROBERT TDirector
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $3.82 | $0.00 |
DisclosureSEC source: 0001437749-21-028133 · rdgdoc.xml · derivative · entry 1 MCNALLY ROBERT T · CIK 0001049435 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2031-12-07 Read SEC document |
| December 07, 2021 Filed Dec 8, 2021 22:22 UTC |
Kollintzas Dean GDirector
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $3.82 | $0.00 |
DisclosureSEC source: 0001437749-21-028132 · rdgdoc.xml · derivative · entry 1 Kollintzas Dean G · CIK 0001378351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2031-12-07 Read SEC document |
| December 07, 2021 Filed Dec 8, 2021 22:22 UTC |
CHASE RANDAL DDirector
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $3.82 | $0.00 |
DisclosureSEC source: 0001437749-21-028131 · rdgdoc.xml · derivative · entry 1 CHASE RANDAL D · CIK 0001078784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2031-12-07 Read SEC document |
| December 07, 2021 Filed Dec 8, 2021 22:21 UTC |
NEWMAN MARK JChief Scientific Officer
|
GrantCommon Stock (right to buy) · Derivative | 25,700 | $0.00 Strike: $3.82 | $0.00 |
DisclosureSEC source: 0001437749-21-028130 · rdgdoc.xml · derivative · entry 1 NEWMAN MARK J · CIK 0001242123 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,700 Underlying: Common Stock · 25,700 shares Expires 2031-12-31 F1 · derivative.exercise_date: Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant. Read SEC document |
| December 07, 2021 Filed Dec 8, 2021 22:19 UTC |
DODD DAVID ADirector · President, CEO
|
GrantStock Option (right to buy) · Derivative | 103,000 | $0.00 Strike: $3.82 | $0.00 |
DisclosureSEC source: 0001437749-21-028127 · rdgdoc.xml · derivative · entry 1 DODD DAVID A · CIK 0001193607 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,000 Underlying: Common Stock · 103,000 shares Expires 2031-12-07 F1 · derivative.exercise_date: Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant. Read SEC document |
| December 07, 2021 Filed Dec 8, 2021 22:20 UTC | GrantStock Option (right to buy) · Derivative | 48,200 | $0.00 Strike: $3.82 | $0.00 |
DisclosureSEC source: 0001437749-21-028129 · rdgdoc.xml · derivative · entry 1 Reynolds Mark · CIK 0001298237 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,200 Underlying: Common Stock · 48,200 shares Expires 2031-12-07 F1 · derivative.exercise_date: Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant. Read SEC document |
|
| August 11, 2021 Filed Aug 11, 2021 21:38 UTC |
DODD DAVID ADirector · President, CEO
|
GrantStock Option (right to buy) · Derivative | 273,000 | $0.00 Strike: $2.79 | $0.00 |
DisclosureSEC source: 0001437749-21-019510 · rdgdoc.xml · derivative · entry 1 DODD DAVID A · CIK 0001193607 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 273,000 Underlying: Common Stock · 273,000 shares Expires 2030-12-02 F1 · date: This stock option was granted on December 2, 2020, with the exercise price set based on the closing price of the underlying common stock as of that date. The stock option was granted contingent upon stockholder approval of an increase in common shares reserved for the company's stock incentive plan. Such approval was obtained on August 11, 2021, so that is the date upon which the stock option is deemed granted pursuant to SEC reporting guidance. F2 · derivative.exercise_date: Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant. Read SEC document |
| August 11, 2021 Filed Aug 11, 2021 21:37 UTC | GrantStock Option (right to buy) · Derivative | 128,000 | $0.00 Strike: $2.79 | $0.00 |
DisclosureSEC source: 0001437749-21-019509 · rdgdoc.xml · derivative · entry 1 Reynolds Mark · CIK 0001298237 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,000 Underlying: Common Stock · 128,000 shares Expires 2030-12-02 F1 · date: This stock option was granted on December 2, 2020, with the exercise price set based on the closing price of the underlying common stock as of that date. The stock option was granted contingent upon stockholder approval of an increase in common shares reserved for the company's stock incentive plan. Such approval was obtained on August 11, 2021, so that is the date upon which the stock option is deemed granted pursuant to SEC reporting guidance. F2 · derivative.exercise_date: Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant. Read SEC document |
|
| August 11, 2021 Filed Aug 11, 2021 21:36 UTC |
NEWMAN MARK JChief Scientific Officer
|
GrantStock Option (right to buy) · Derivative | 35,000 | $0.00 Strike: $2.79 | $0.00 |
DisclosureSEC source: 0001437749-21-019507 · rdgdoc.xml · derivative · entry 1 NEWMAN MARK J · CIK 0001242123 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2030-12-02 F1 · date: This stock option was granted on December 2, 2020, with the exercise price set based on the closing price of the underlying common stock as of that date. The stock option was granted contingent upon stockholder approval of an increase in common shares reserved for the company's stock incentive plan. Such approval was obtained on August 11, 2021, so that is the date upon which the stock option is deemed granted pursuant to SEC reporting guidance. F2 · derivative.exercise_date: Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant. Read SEC document |
| August 11, 2021 Filed Aug 11, 2021 21:35 UTC |
Kollintzas Dean GDirector
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $2.79 | $0.00 |
DisclosureSEC source: 0001437749-21-019506 · rdgdoc.xml · derivative · entry 1 Kollintzas Dean G · CIK 0001378351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2030-12-02 F1 · date: This stock option was granted on December 2, 2020, with the exercise price set based on the closing price of the underlying common stock as of that date. The stock option was granted contingent upon stockholder approval of an increase in common shares reserved for the company's stock incentive plan. Such approval was obtained on August 11, 2021, so that is the date upon which the stock option is deemed granted pursuant to SEC reporting guidance. F2 · derivative.exercise_date: Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant. Read SEC document |
| August 11, 2021 Filed Aug 11, 2021 21:34 UTC |
MCNALLY ROBERT TDirector
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $2.79 | $0.00 |
DisclosureSEC source: 0001437749-21-019505 · rdgdoc.xml · derivative · entry 1 MCNALLY ROBERT T · CIK 0001049435 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2030-12-02 F1 · date: This stock option was granted on December 2, 2020, with the exercise price set based on the closing price of the underlying common stock as of that date. The stock option was granted contingent upon stockholder approval of an increase in common shares reserved for the company's stock incentive plan. Such approval was obtained on August 11, 2021, so that is the date upon which the stock option is deemed granted pursuant to SEC reporting guidance. F2 · derivative.exercise_date: Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant. Read SEC document |
| August 11, 2021 Filed Aug 11, 2021 21:33 UTC |
CHASE RANDAL DDirector
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $2.79 | $0.00 |
DisclosureSEC source: 0001437749-21-019504 · rdgdoc.xml · derivative · entry 1 CHASE RANDAL D · CIK 0001078784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2030-12-02 F1 · date: This stock option was granted on December 2, 2020, with the exercise price set based on the closing price of the underlying common stock as of that date. The stock option was granted contingent upon stockholder approval of an increase in common shares reserved for the company's stock incentive plan. Such approval was obtained on August 11, 2021, so that is the date upon which the stock option is deemed granted pursuant to SEC reporting guidance. F2 · derivative.exercise_date: Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant. Read SEC document |
| August 11, 2021 Filed Aug 11, 2021 21:31 UTC |
SPENCER JOHN N JRDirector
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $2.79 | $0.00 |
DisclosureSEC source: 0001437749-21-019503 · rdgdoc.xml · derivative · entry 1 SPENCER JOHN N JR · CIK 0001270555 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2030-12-02 F1 · date: This stock option was granted on December 2, 2020, with the exercise price set based on the closing price of the underlying common stock as of that date. The stock option was granted contingent upon stockholder approval of an increase in common shares reserved for the company's stock incentive plan. Such approval was obtained on August 11, 2021, so that is the date upon which the stock option is deemed granted pursuant to SEC reporting guidance. F2 · derivative.exercise_date: Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant. Read SEC document |
| September 29, 2020 Filed Sep 29, 2020 22:29 UTC | PurchaseCommon Stock Purchase Warrant · Derivative | 60,184 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001437749-20-020454 · rdgdoc.xml · derivative · entry 2 Reynolds Mark · CIK 0001298237 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,184 Underlying: Common Stock · 60,184 shares Expires 2025-09-29 F1 · derivative.exercise_date: These securities are subject to a lock-up agreement, dated August 31, 2020, between the Reporting Person and Maxim Group LLC. The securities may not be sold, exercised, or otherwise transferred prior to March 29, 2021, unless the restrictions are earlier waived by Maxim Group LLC or pursuant to specific exemptions in the lock-up agreement. Read SEC document |
|
| September 29, 2020 Filed Sep 29, 2020 22:29 UTC | PurchaseCommon Stock | 60,184 | $5.00 | $300,920.00 |
DisclosureSEC source: 0001437749-20-020454 · rdgdoc.xml · nonDerivative · entry 1 Reynolds Mark · CIK 0001298237 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,184 F1 · balance_after: These securities are subject to a lock-up agreement, dated August 31, 2020, between the Reporting Person and Maxim Group LLC. The securities may not be sold, exercised, or otherwise transferred prior to March 29, 2021, unless the restrictions are earlier waived by Maxim Group LLC or pursuant to specific exemptions in the lock-up agreement. Read SEC document |
|
| September 29, 2020 Filed Sep 29, 2020 22:28 UTC |
DODD DAVID ADirector · President, CEO
|
PurchaseCommon Stock Purchase Warrant · Derivative | 81,870 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001437749-20-020453 · rdgdoc.xml · derivative · entry 2 DODD DAVID A · CIK 0001193607 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,870 Underlying: Common Stock · 81,870 shares Expires 2025-09-29 F1 · derivative.exercise_date: These securities are subject to a lock-up agreement, dated August 31, 2020, between the Reporting Person and Maxim Group LLC. The securities may not be sold, exercised, or otherwise transferred prior to March 29, 2021, unless the restrictions are earlier waived by Maxim Group LLC or pursuant to specific exemptions in the lock-up agreement. Read SEC document |
| September 29, 2020 Filed Sep 29, 2020 22:28 UTC |
DODD DAVID ADirector · President, CEO
|
PurchaseCommon Stock | 81,870 | $5.00 | $409,350.00 |
DisclosureSEC source: 0001437749-20-020453 · rdgdoc.xml · nonDerivative · entry 1 DODD DAVID A · CIK 0001193607 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,870 F1 · balance_after: These securities are subject to a lock-up agreement, dated August 31, 2020, between the Reporting Person and Maxim Group LLC. The securities may not be sold, exercised, or otherwise transferred prior to March 29, 2021, unless the restrictions are earlier waived by Maxim Group LLC or pursuant to specific exemptions in the lock-up agreement. Read SEC document |
| September 29, 2020 Filed Sep 29, 2020 22:28 UTC |
MCNALLY ROBERT TDirector
|
PurchaseCommon Stock Purchase Warrant · Derivative | 53,925 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001437749-20-020452 · rdgdoc.xml · derivative · entry 2 MCNALLY ROBERT T · CIK 0001049435 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,925 Underlying: Common Stock · 53,925 shares Expires 2025-09-29 F1 · derivative.exercise_date: These securities are subject to a lock-up agreement, dated August 31, 2020, between the Reporting Person and Maxim Group LLC. The securities may not be sold, exercised, or otherwise transferred prior to March 29, 2021, unless the restrictions are earlier waived by Maxim Group LLC or pursuant to specific exemptions in the lock-up agreement. Read SEC document |
| September 29, 2020 Filed Sep 29, 2020 22:28 UTC |
MCNALLY ROBERT TDirector
|
PurchaseCommon Stock | 53,925 | $5.00 | $269,625.00 |
DisclosureSEC source: 0001437749-20-020452 · rdgdoc.xml · nonDerivative · entry 1 MCNALLY ROBERT T · CIK 0001049435 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,925 F1 · balance_after: These securities are subject to a lock-up agreement, dated August 31, 2020, between the Reporting Person and Maxim Group LLC. The securities may not be sold, exercised, or otherwise transferred prior to March 29, 2021, unless the restrictions are earlier waived by Maxim Group LLC or pursuant to specific exemptions in the lock-up agreement. Read SEC document |
| September 29, 2020 Filed Sep 29, 2020 22:27 UTC |
SPENCER JOHN N JRDirector
|
PurchaseCommon Stock Purchase Warrant · Derivative | 21,024 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001437749-20-020451 · rdgdoc.xml · derivative · entry 2 SPENCER JOHN N JR · CIK 0001270555 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,024 Underlying: Common Stock · 21,024 shares Expires 2025-09-29 F1 · derivative.exercise_date: These securities are subject to a lock-up agreement, dated August 31, 2020, between the Reporting Person and Maxim Group LLC. The securities may not be sold, exercised, or otherwise transferred prior to March 29, 2021, unless the restrictions are earlier waived by Maxim Group LLC or pursuant to specific exemptions in the lock-up agreement. Read SEC document |
| September 29, 2020 Filed Sep 29, 2020 22:27 UTC |
SPENCER JOHN N JRDirector
|
PurchaseCommon Stock | 21,024 | $5.00 | $105,120.00 |
DisclosureSEC source: 0001437749-20-020451 · rdgdoc.xml · nonDerivative · entry 1 SPENCER JOHN N JR · CIK 0001270555 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,024 F1 · balance_after: These securities are subject to a lock-up agreement, dated August 31, 2020, between the Reporting Person and Maxim Group LLC. The securities may not be sold, exercised, or otherwise transferred prior to March 29, 2021, unless the restrictions are earlier waived by Maxim Group LLC or pursuant to specific exemptions in the lock-up agreement. Read SEC document |
| September 29, 2020 Filed Sep 29, 2020 22:19 UTC |
CHASE RANDAL DDirector
|
PurchaseCommon Stock Purchase Warrant · Derivative | 16,613 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001437749-20-020449 · rdgdoc.xml · derivative · entry 2 CHASE RANDAL D · CIK 0001078784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,613 Underlying: Common Stock · 16,613 shares Expires 2025-09-29 F1 · derivative.exercise_date: These securities are subject to a lock-up agreement, dated August 31, 2020, between the Reporting Person and Maxim Group LLC. The securities may not be sold, exercised, or otherwise transferred prior to March 29, 2021, unless the restrictions are earlier waived by Maxim Group LLC or pursuant to specific exemptions in the lock-up agreement. Read SEC document |
| September 29, 2020 Filed Sep 29, 2020 22:19 UTC |
CHASE RANDAL DDirector
|
PurchaseCommon Stock | 16,613 | $5.00 | $83,065.00 |
DisclosureSEC source: 0001437749-20-020449 · rdgdoc.xml · nonDerivative · entry 1 CHASE RANDAL D · CIK 0001078784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,613 F1 · balance_after: These securities are subject to a lock-up agreement, dated August 31, 2020, between the Reporting Person and Maxim Group LLC. The securities may not be sold, exercised, or otherwise transferred prior to March 29, 2021, unless the restrictions are earlier waived by Maxim Group LLC or pursuant to specific exemptions in the lock-up agreement. Read SEC document |
| September 29, 2020 Filed Sep 29, 2020 22:26 UTC |
Kollintzas Dean GDirector
|
PurchaseCommon Stock Purchase Warrant · Derivative | 11,987 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001437749-20-020450 · rdgdoc.xml · derivative · entry 2 Kollintzas Dean G · CIK 0001378351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,987 Underlying: Common Stock · 11,987 shares Expires 2025-09-29 F2 · derivative.exercise_date: These securities are subject to a lock-up agreement, dated August 31, 2020, between the Reporting Person and Maxim Group LLC. The securities may not be sold, exercised, or otherwise transferred prior to March 29, 2021, unless the restrictions are earlier waived by Maxim Group LLC or pursuant to specific exemptions in the lock-up agreement. Read SEC document |
| September 29, 2020 Filed Sep 29, 2020 22:26 UTC |
Kollintzas Dean GDirector
|
PurchaseCommon Stock | 11,987 | $5.00 | $59,935.00 |
DisclosureSEC source: 0001437749-20-020450 · rdgdoc.xml · nonDerivative · entry 1 Kollintzas Dean G · CIK 0001378351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,987 F1 · balance_after: These securities are subject to a lock-up agreement, dated August 31, 2020, between the Reporting Person and Maxim Group LLC. The securities may not be sold, exercised, or otherwise transferred prior to March 29, 2021, unless the restrictions are earlier waived by Maxim Group LLC or pursuant to specific exemptions in the lock-up agreement. Read SEC document |
| December 17, 2018 Filed Dec 19, 2018 20:39 UTC |
SPENCER JOHN N JRDirector
|
GrantCommon Stock Purchase Option · Derivative | 345,000 | $0.00 Strike: $0.03 | $0.00 |
DisclosureSEC source: 0001437749-18-022299 · rdgdoc.xml · derivative · entry 1 SPENCER JOHN N JR · CIK 0001270555 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 345,000 Underlying: Common Stock · 345,000 shares Expires 2028-12-17 F1 · derivative.exercise_date: Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant. Read SEC document |
| December 17, 2018 Filed Dec 19, 2018 20:39 UTC |
MCNALLY ROBERT TDirector
|
GrantCommon Stock Purchase Option · Derivative | 650,000 | $0.00 Strike: $0.03 | $0.00 |
DisclosureSEC source: 0001437749-18-022298 · rdgdoc.xml · derivative · entry 1 MCNALLY ROBERT T · CIK 0001049435 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 650,000 Underlying: Common Stock · 650,000 shares Expires 2028-12-17 F1 · derivative.exercise_date: Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant. Read SEC document |
| December 17, 2018 Filed Dec 19, 2018 20:39 UTC |
Kollintzas Dean GDirector
|
GrantCommon Stock Purchase Option · Derivative | 300,000 | $0.00 Strike: $0.03 | $0.00 |
DisclosureSEC source: 0001437749-18-022297 · rdgdoc.xml · derivative · entry 1 Kollintzas Dean G · CIK 0001378351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2028-12-17 F1 · derivative.exercise_date: Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant. Read SEC document |
| December 17, 2018 Filed Dec 19, 2018 20:38 UTC |
ROBINSON HARRIET LDirector · CSO Emeritus
|
GrantCommon Stock Purchase Option · Derivative | 600,000 | $0.00 Strike: $0.03 | $0.00 |
DisclosureSEC source: 0001437749-18-022295 · rdgdoc.xml · derivative · entry 1 ROBINSON HARRIET L · CIK 0001377780 · Director · CSO Emeritus 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600,000 Underlying: Common Stock · 600,000 shares Expires 2028-12-17 F1 · derivative.exercise_date: Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant. Read SEC document |
| December 17, 2018 Filed Dec 19, 2018 20:39 UTC |
CHASE RANDAL DDirector
|
GrantCommon Stock Purchase Option · Derivative | 320,000 | $0.00 Strike: $0.03 | $0.00 |
DisclosureSEC source: 0001437749-18-022296 · rdgdoc.xml · derivative · entry 1 CHASE RANDAL D · CIK 0001078784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 320,000 Underlying: Common Stock · 320,000 shares Expires 2028-12-17 F1 · derivative.exercise_date: Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant. Read SEC document |
| December 17, 2018 Filed Dec 19, 2018 20:38 UTC | GrantCommon Stock Purchase Option · Derivative | 750,000 | $0.00 Strike: $0.03 | $0.00 |
DisclosureSEC source: 0001437749-18-022294 · rdgdoc.xml · derivative · entry 1 Reynolds Mark · CIK 0001298237 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 750,000 Underlying: Common Stock · 750,000 shares Expires 2028-12-17 F1 · derivative.exercise_date: Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant. Read SEC document |
|
| December 17, 2018 Filed Dec 19, 2018 20:31 UTC |
Guirakhoo FarshadChief Scientific Officer
|
GrantCommon Stock Purchase Option · Derivative | 625,000 | $0.00 Strike: $0.03 | $0.00 |
DisclosureSEC source: 0001437749-18-022291 · rdgdoc.xml · derivative · entry 1 Guirakhoo Farshad · CIK 0001656602 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 625,000 Underlying: Common Stock · 625,000 shares Expires 2028-12-17 F1 · derivative.exercise_date: Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant. Read SEC document |
| December 17, 2018 Filed Dec 19, 2018 20:27 UTC |
DODD DAVID ADirector · President, CEO
|
GrantCommon Stock Purchase Option · Derivative | 785,000 | $0.00 Strike: $0.03 | $0.00 |
DisclosureSEC source: 0001437749-18-022288 · rdgdoc.xml · derivative · entry 1 DODD DAVID A · CIK 0001193607 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 785,000 Underlying: Common Stock · 785,000 shares Expires 2028-12-17 F1 · derivative.exercise_date: Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.